GHK-Cu · Mechanism of Action
Mechanism of Action
In published research, GHK-Cu (GHK-Cu (Copper Tripeptide-1)) is characterized as a research peptide that is studied primarily through its interaction with copper transport. The summary below describes the mechanisms reported in the scientific literature at a molecular level. It is educational reference information about laboratory study models, not a description of effects in humans.
Reported molecular targets
The research literature associates GHK-Cu with copper transport, collagen / ECM gene expression, and antioxidant pathways. These are the interaction points most frequently referenced when the compound is discussed in mechanistic studies.
As with any research material, the precise pathways reported vary by model system, and findings are drawn from in-vitro and preclinical work rather than human data.
- Primary target
- copper transport
- Also referenced
- collagen / ECM gene expression
- Also referenced
- antioxidant pathways
Where this mechanism is studied
Mechanistic work involving GHK-Cu appears most often in the context of skin-regeneration research, wound-healing models, and ECM-remodeling studies. Investigators use these model systems to characterize the compound's behavior, not to establish any human application.
Blueprint Labs supplies GHK-Cu as a lyophilized powder (≥98% (HPLC + LC-MS verified)) for exactly this kind of controlled laboratory study.
Reading this responsibly
Mechanistic descriptions summarize what researchers have reported about molecular interactions. They are not evidence of safety or benefit in any organism, and they are not instructions for use. For research use only. Not for human consumption, diagnostic, or therapeutic use.
Available from Blueprint Labs
GHK-Cu 50mg
Third-party tested, GHK-Cu supplied as a research material with a certificate of analysis available.
Questions, answered
What is the reported mechanism of GHK-Cu?
Published research describes GHK-Cu in terms of copper transport and related signaling. This is a generic summary of laboratory findings, not a statement about effects in people.
Does this describe what GHK-Cu does in humans?
No. Everything here summarizes in-vitro and preclinical research models. For research use only. Not for human consumption, diagnostic, or therapeutic use.
Is GHK-Cu a small molecule or a peptide?
GHK-Cu is classified as a research peptide (molecular weight 403.92 g/mol (copper complex)).